ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cedrik Britten, M.D.
Immatics US, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universitätsklinikum Heidelberg, Nationales Centrum Für Tumorerkrankungen (nct)
Heidelberg, Baden-Wurttemberg, Germany
Recruiting - Klinikum Rechts Der Isar Der Technischen Universität München
Munich, Bavaria, Germany
Recruiting - Universitätsklinikum Würzburg
Würzburg, Bavaria, Germany
Recruiting - Universitätsklinikum Bonn - Medizinische Klinik Iii
Bonn, North Rhine-Westphalia, Germany
Recruiting - Universitätsmedizin Der Johannes Gutenberg-Universität Mainz
Mainz, Rhineland-Palatinate, Germany
Recruiting - Universitätsklinikum C.-G.-Carus Dresden
Dresden, Saxony, Germany
Recruiting - Charité Benjamin Franklin - Klinik Für Hämatologie Und Onkologie
Berlin, Germany
Recruiting - Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
Recruiting
- Stanford Cancer Institute
Stanford, California, United States
Recruiting - University of Colorado, Anschutz Medical Campus
Aurora, Colorado, United States
Recruiting - University of Miami Hospital and Clinics
Miami, Florida, United States
Recruiting - University of Chicago Medical Center
Chicago, Illinois, United States
Recruiting - Massachusetts General Hospital
Boston, Massachusetts, United States
Recruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting - Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run
Columbus, Ohio, United States
Recruiting - Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Anthony Olszanski, MDRecruiting - Thomas Jefferson University, Honickman Center
Philadelphia, Pennsylvania, United States
Recruiting - University of Pennsylvania, Perelamn Center for Advanced Medicine
Philadelphia, Pennsylvania, United States
Recruiting - University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Jason Luke, M.D.Recruiting - University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Dejka M Araujo, M.D.Recruiting - Fred Hutchinson Cancer Center
Seattle, Washington, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 May 2019
- Primary completion
- 31 Dec 2028
- Completion
- 30 Jun 2032
- Last update posted
- 13 May 2026
- Registered enrollment
- 375
- Registry id
- NCT03686124
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.